Feed AFX.DE
AF

Carl Zeiss AFX.DE · XETRA

35.44 € -0.28% (-0.10 €)

Market cap
3.05B €
Enterprise value
3.05B €
P/E
26.2x
Forward P/E
24.0x
PEG
-
P/S
1.2x
P/FCF
11.2x
EV/EBITDA
9.2x
ROIC
-
Gross margin
51.0%
Net margin
4.4%
Dividend yield
1.58%
Payout ratio
41.3%
Net debt/EBITDA
0.0x
Beta
1.33
Free float
39.1%

About the company

Carl Zeiss Meditec AG is a German company headquartered in Jena, specializing in the development, manufacturing, and sale of medical technologies and devices for ophthalmology and neurosurgery. Their products include advanced diagnostic and surgical systems such as ophthalmic microscopes, laser systems for vision correction, diagnostic examination devices, and image analysis software. Carl Zeiss Meditec is known for its innovative technologies and high quality products that contribute to the treatment of eye diseases and neurosurgical procedures. The company has a global presence and is recognized as a leader in the field of ophthalmic and neurosurgical medical technologies. Shares of Carl Zeiss Meditec AG are publicly traded on the German stock exchange.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Andreas Pecher

Employees

5,784

Headquarters

Jena

Valuation

Is today's price reasonable?

  • What speaks for it: The share price is below the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What to watch: Earnings per share fell by 21% a year over the last 3 years.
  • What to watch: It missed profit estimates 4 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

  • What speaks for it: It could repay all its net debt from 0.0 years of operating profit.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy